Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors
-
Atea Announces Presentation of Data Highlighting Favorable Safety Profile of Bemnifosbuvir at ESCMID Global 2024
-
AI Networking Innovator Nile Continues to Expand its Executive Team; Adding Stephen Patak as CRO and Surbhi Kaul as VP, Customer Experience
-
Xtract One Technologies Awarded U.S. Department of Homeland Security SAFETY Act Designation for Multi-Sensor Gateway Portfolio
-
Boston orders 80 advanced zero-emission buses from NFI subsidiary New Flyer with options to purchase an additional 380 buses
-
FibroGen to Report First Quarter 2024 Financial Results
-
Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.
-
Cielo Confirms Key Equipment Order and Environmental Permit Application, Advancing the Company’s Carseland Bio-SynDiesel® Project Towards Commercialization and Shares for Debt Transaction
-
Amwell Releases 2024 Corporate Responsibility Report
-
Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingua
-
MoneyHero Group Reports Fourth Quarter and Full Year 2023 Results
-
Arqit announces collaboration to deliver out-of-the-box post-quantum cryptography solutions
-
Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
-
Standard Uranium Prepares to Mobilize for JV-Partner Funded Inaugural Drill Program at Canary Project, Eastern Athabasca Basin
-
Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer
-
GRAY TELEVISION ROLLING OUT ADVANCED FEATURES WITH NEXTGEN TV
-
Breckenridge Brewery Introduces New West Coast Style IPA ‘Ridge Runner’
-
OTC Markets Group Welcomes Mackenzie Realty Capital, Inc. to OTCQX
-
Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement
-
Transfer of shares held by Verkkokauppa.com Oyj for the payment of the remuneration to the Board of Directors - change in company’s treasury shares
-
ECARX to Report First Quarter 2024 Financial Results on May 20, 2024
-
CNH expands network connectivity with Intelsat collaboration
-
George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director
-
Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program
-
BAORUI Applied New Security Measures to Protect Investors from Scams: Redefining Security in Crypto Trading
-
Operating hashrate increased to 9 EH/s
-
Ocugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024
-
Gravitas Worldwide Streamlines Customs Clearance Using Descartes e-Customs™ Solution
-
Gildan Activewear Files Proxy Circular and Board of Directors Issues Letter to Shareholders
-
Award-Winning Biophilic Artist Susie Frazier to Hold Neuroinclusion Media Event at the WELL Conference on May 7
-
Reporting of transactions made by members of the Board of Directors or Executive Management or their closely associated persons
-
X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor) Capsules, First Drug Indicated in Patients with WHIM Syndrome
-
AirBoss Awarded Bandolier Contract Valued at up to US$45 million
-
Alberta Motor Association Insurance Company Selects IMS for Pay-As-You-Go Program
-
Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for tre
-
Parsons Wins Position on $464M U.S. Army Remediation Contract
-
Sampo Group's results for January–March 2024 will be published on 7 May 2024
-
MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation Suspension for Nontuberculous Mycobacterial (NTM) Lung Disease
-
Liberty Gold Announces C$9.5 Million Non-Brokered Private Placement Financing
-
Provident Financial Holdings Reports Third Quarter Fiscal Year 2024 Results
-
Comstock’s Physics-Based AI Investment Emerges From Stealth
-
Buildings across the nation to light up green for Mental Health Month in May
-
PRIMERICA ALERT: Bragar Eagel & Squire, P.C. is Investigating Primerica Inc. on Behalf of Primerica Stockholders and Encourages Investors to Contact the Firm
-
Enerflex Prevails in Appeal of Mexican Labor Board Decision and Announces Timing of First Quarter Results
-
Trump Media Provides Additional Information to DJT Investors Regarding Recalling Shares
-
First Quarter Report 2024
-
Coave Therapeutics Showcases its ALIGATER™ Platform for Generating Conjugated AAV (coAAV) Vectors Exhibiting Superior Performance in Delivering Ocular Gene Therapy through the Suprachoroidal Route
-
Dimensional Fund Advisors Ltd. : Form 8.3 - UK COMMERCIAL PROPERTY REIT - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TRITAX BIG BOX REIT PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - QUANEX BUILDING PRODUCTS - Ordinary Shares
